Quality of life in black African patients with keloid scars

  • Komenan Kassi | siskakomlo@yahoo.fr Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.
  • Kanga Kouame Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.
  • Alexandre Kouassi Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.
  • Ange Allou Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.
  • Isidore Kouassi Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.
  • Sarah Kourouma Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.
  • Elidje Ecra Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.
  • Abdoulaye Sangare Department of dermatology and venerology, Training and research units of medical sciences, University of Felix Houphouet-Boigny of Abidjan, Côte d'Ivoire.

Abstract

A keloid scar is a benign skin tumor and we aimed to assess the Quality of Life (QoL) of black Africans with keloid scars based on the Dermatology Life Quality Index (DLQI). We conducted a cross-sectional descriptive study in the department of dermatology of the teaching hospital of Treichville in Ivory Coast. We recruited 132 patients with keloid and 3612 dermatoses without keloid: The prevalence was 3.50% (132/3753). We included 120 patients aged from 16 to 63 years old, the sex ratio was 0.46 (38/82) and the mean age was 34.20 years. Keloid scars were mostly secondary to skin trauma in 30.00 % and infection in 21.67%. The commonest site was the ear in 29.17 %. We reported Keloid with pain in 53.33% and pruritus in 95.00%. We observed psychological impact in 65.83%. The DLQI scores were moderate and high in 61.66 %. QoL was impacted significantly when keloid was associated with pain (p=0.046), pruritus (p=0.81) and functional disorders (p=0.29). The DLQI score could be a valuable tool to assess QoL in black African patients with keloid, for better treatment option.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

1-Hunasgi S, Koneru A, Vinishra M,et al. Keloid: A case report and review of pathophysiology and diffenrences between keloid and hypertrophic scars. J oral Maxillofac. Pathol 2013; 17: 116-20.
2-A Paul Kelly. Update on the management of keloid. SeminCutan Med Surg. 2009; 28:72-8.
3-Robles DT, Berg D: Abnormal wound healing: keloids: Clin Dermatol. 2007; 25:26-32
4-Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011; 17: 113–125.
5-Bijlard E, Konwenberg C, Reiner Timman R,et al. Berden of keloid disease: A cross-sectional health-related quality of life assessment. Acta Derma Venerol 2017;97: 225-9.

6-Lemonas P, Ahmad I, Falvey H, et al. Keloid scars: the hidden burden of disease. Pigmentary Disorders 2015; 2:12: 31.

7-Goldstein BG, Goldstein AD. Keloid. In Dellavalh RP, Levy ML, Editors, up to date. Waltham MA: up to date, 2014./ Furtado F, Hochman B, Ferrara SF, et al. What factors affect the quality of life of patients with keloids ? Revista Da Associacos Medica Brasileira 2009; 57: 700-4.
8- Konwenberg C, Bijlard E, Timman R, et al. Emotionl quality of life is severely affected by keloid diseases: pain and itch are the main determinants of burden. Plastic and Reconstructive Surgery 136; 43-1: 150-1.

9-Brown BC, McKenna SP, Sickdih K, et al. The hidden cost of skin scars: quality of life after skin scaring. J Plast Reconstr Aesthet Surg. 2008; 61: 1049-58.

10- Carr T, Moss T Harris. The DAS24: a short form of the Derriford appearance scale DAS54 to measure individual responses to learning with problem of appearance. Br J Health Psychol 2005; 10: 285-95.

11-Balci DD, Inandi T, Dogramaci CA, et al. DLQI scores in patients with
keloids and hypertrophic scars: a prospective case control study. J Dtsch Dermatol Ges 2009; 7: 688–92.
12-Morales-Sanchez M A, Flores-Ruvalcaba C N, Peralta-Pedrero M L et al. Quality of life in adults with keloid scars. Cir Cir 2018; 86: 321-6.
13-Brown BC, Moss TP, McGrouther DA, et al. Skin scar preconceptions
must be challenged: importance of self-perception in skin scarring. J Plast
Reconstr Aesthet Surg 2010; 63: 1022–9.
14-Reinholz M, Poetshke J, Schwaiger H,et al. The Dermatology life quality index as a mean to assess life quality in patients with different scar types. JEADV 2015; 29: 2112-9.
15-Olaitan PB. Keloids : Assessment of affects psychosocial-impacts on subjects in black African population.Idian J Dermatol Venerol Leprol 2009 ; 75 :368-72.
16-Poetschke J, Reinholz M, Schwaiger H, et al. DLQI and POSAS scores in keloid patients. Facial Plast Surg 2016; 37: 289-95.
17-Gauglitz GG. Management of keloids and hypertrophic scars: current and
emerging options. Clin Cosmet Investig Dermatol 2013; 6: 103–14.
18- S, Ud-Din and A. Bayat. Strategic management of keloid disease in ethnic skin: a structure approach supported by the emerging literature.BJD 2013; 169:71-81
19-Gold MH, Berman B, Clementoni MT, et al. Updated international clinical recommendations on scar management: part 1-evaluating the evidence. Dermatol Surg 2014; 40: 817–824.
Published
2020-10-22
Info
Issue
Section
Articles
Keywords:
Keloid, Black African, QoL, DLQI
Statistics
  • Abstract views: 517

  • PDF: 75
How to Cite
Kassi, K., Kouame, K., Kouassi, A., Allou, A., Kouassi, I., Kourouma, S., Ecra, E., & Sangare, A. (2020). Quality of life in black African patients with keloid scars. Dermatology Reports, 12(2). https://doi.org/10.4081/dr.2020.8312